H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Applied DNA Sciences (APDN) today and set a price target of $14.00. The company’s shares closed last Thursday at $12.57.
According to TipRanks.com, Chen is a top 25 analyst with an average return of 92.2% and a 66.0% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Currently, the analyst consensus on Applied DNA Sciences is a Moderate Buy with an average price target of $14.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $16.39 and a one-year low of $2.52. Currently, Applied DNA Sciences has an average volume of 1.39M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Read More on APDN:
